Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cell-Matrix is a Japanese life science company specializing in the development and manufacture of high-quality extracellular matrix (ECM) products, particularly collagen for cell culture and tissue engineering. Founded in 1989 as a joint venture involving Nitta Gelatin, the company provides essential reagents and materials that support advanced biomedical research, including cancer cell invasion assays and regenerative medicine studies. Their flagship product line, marketed under the brand name Cellmatrix, includes various types of purified collagen (Type I, III, and IV) used globally by academic and industrial researchers. While primarily a tools and reagents provider, Cell-Matrix's technologies are foundational for drug discovery platforms and the development of complex 3D cell culture models.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cell-Matrix.